IMGN News and Press, ImmunoGen Inc. From 02/08/19

ImmunoGen, Inc. (IMGN) Q4 2018 Results Earnings Conference Call February 08, 2019 08:00 AM ET Company Participants Courtney O’Konek - Corporate Communications Mark Enyedy - President and CEO Anna Berkenblit - CMO Rich Gregory - Chief Scientific Officer Blaine Mckee - ...

Coty (NYSE: COTY ) +27%  on Q2 earnings . More news on: Coty Inc., eGain Communications Corp., Skechers USA Inc., , Stocks on the move Read more ...

ImmunoGen ( IMGN ) Q4 results : Revenues: $13.8M (-65.0%); License and milestone fees: $1.7M (-94.3%); Non-cash royalty revenue: $9.7M (+27.6%); R&D support: $0.2M (-60.0%); Clinical materials revenue: $2.2M (+22.2%). More news on: ImmunoGen, Inc., Healthcare stocks news, Earnings new...

ImmunoGen (NASDAQ: IMGN ): Q4 GAAP EPS of -$0.28 beats by $0.04 . More news on: ImmunoGen, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

Top-Line Data from Phase 3 FORWARD I Mirvetuximab Soravtansine Study on Track for First Half of 2019 Encouraging Clinical Data from Novel IGN Pipeline Highlighted in Two Oral Presentations at ASH 2018 Sale of Kadcyla ® Royalty Tail for $65 Million Further Strengthens Fin...

ImmunoGen (NASDAQ: IMGN ) is scheduled to announce Q4 earnings results on Friday, February 8th, before market open. More news on: ImmunoGen, Inc., Earnings news and commentary, , Healthcare stocks news, Read more ...

ARNC , AVA , BPL , CAE , CBOE , CLF , COTY , EAF , ESNT , EXC , GT , HAS , IMGN , PSX , PSXP , RDN , UNVR , VTR For Seeking Alpha's full earnings season calendar,  click here . More news on: Arconic Inc, Avista Corporation, Buckeye Partners L.P., Earnings news a...

ImmunoGen, Inc. , (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that the Company will host a conference call at 8:00 a.m. ET on Friday, February 8, 2019 to discuss its 2018 operating resu...